JHS — JHS Svendgaard Laboratories Income Statement
0.000.00%
- IN₹2.27bn
- IN₹2.20bn
- IN₹707.98m
- 25
- 27
- 55
- 23
Annual income statement for JHS Svendgaard Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,391 | 1,008 | 863 | 962 | 708 |
Cost of Revenue | |||||
Gross Profit | 307 | 241 | 180 | 202 | 186 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,461 | 1,061 | 941 | 1,314 | 773 |
Operating Profit | -69.8 | -52.9 | -78.9 | -352 | -64.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -58.4 | 9.68 | 1.03 | -218 | -34.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -48.5 | 13.4 | -42.9 | -168 | -40.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -19.8 | 12 | -40.5 | -155 | -40.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -19.8 | 12 | -40.5 | -155 | -40.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.808 | 0.201 | -0.624 | -0.517 | -0.575 |